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Abstract
Background: The European DISABKIDS project aims to enhance the Health Related Quality of Life
(HRQoL) of children and adolescents with chronic medical conditions and their families. We describe the
development of the seven cross-nationally tested condition-specific modules of the European DISABKIDS
HRQoL instrument in a population of children and adolescents. The condition-specific modules are
intended for use in conjunction with the DISABKIDS chronic generic module.
Methods: Focus groups were used to construct the pilot version of the DISABKIDS condition-specific
HRQoL modules for asthma, juvenile idiopathic arthritis, atopic dermatitis, cerebral palsy, cystic fibrosis,
diabetes and epilepsy. Analyses were conducted on pilot test data in order to construct field test versions
of the modules. A series of factor analyses were run, first, to determine potential structures for each
condition-specific module, and, secondly, to select a reduced number of items from the pilot test to be
included in the field test. Post-field test analyses were conducted to retest the domain structure for the
final DISABKIDS condition-specific modules.
Results: The DISABKIDS condition-specific modules were tested in a pilot study of 360 respondents, and
subsequently in a field test of 1152 respondents in 7 European countries. The final condition-specific
modules consist of an 'Impact' domain and an additional domain (e.g. worry, stigma, treatment) with
between 10 to 12 items in total. The Cronbach's alpha of the final domains was found to vary from 0.71
to 0.90.
Conclusion: The condition-specific modules of the DISABKIDS instrument were developed through a
step-by-step process including cognitive interview, clinical expertise, factor analysis, correlations and
internal consistency. A cross-national pilot and field test were necessary to collect these data. In general,
the internal consistency of the domains was satisfactory to high. In future, the DISABKIDS instrument may
serve as a useful tool with which to assess HRQoL in children and adolescents with a chronic condition.
The condition-specific modules can be used in conjunction with the DISABKIDS chronic generic module.
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Background
The last few decades have seen an increase in the amount
of constructed Health Related Quality of Life (HRQoL)
questionnaires for use with children and adolescents
[1,2]. Although a number of questionnaires have been
used for evaluative studies the questionnaires are only
occasionally used in paediatric clinical trials or clinical
practice [3-5]. The expectation is that the implementation
of HRQoL questionnaires will increase once a number of
aspects of HRQoL research are improved.
One area of improvement concerns the need for valid
cross-national questionnaires for use in international
research [6-8]. Most questionnaires have been developed
in one country and are then translated for use in other
countries (sequential approach) [9]. This is thought to
have its limitations as true compatibility is not necessarily
reached [8,10]. A preferred design for the development of
cross-national questionnaires is to construct a question-
naire in several countries through a simultaneous
approach [8,9]. A questionnaire that was developed in
simultaneous collaboration with different countries is the
World Health Organization Quality of Life (WHOQOL)
questionnaire, but it is only for use in adults [11].
Investigators have also suggested further improvement of
HRQoL questionnaires by combining generic and condi-
tion-specific modules to offer sufficient detail in the
assessment of HRQoL [12]. Generic questionnaires are
generally used in HRQoL research and enable compari-
sons between groups of interest (i.e. different chronic
medical conditions). Supplementing a generic module
with a condition-specific module is suggested to provide
additional information concerning a specific condition
and has the potential to identify smaller changes impor-
tant to research or clinical practice [12-14]. Examples of
these are the 'How are you?' (HAY)-asthma [15,16] and
the Paediatric Quality of Life Inventory (PedsQL™)
[17,18], which both consist of a generic core scale with an
additional asthma module.
However, thus far there were no HRQoL questionnaires
that were developed in several countries simultaneously
and consisted of a chronic generic and condition-specific
module for use in children and adolescents with a variety
of chronic medical conditions. The European DISABKIDS
project aimed to provide in this need. The project was
conducted simultaneously in collaboration with seven
European countries and developed a series of modules to
assess the HRQoL of children and adolescents who suffer
from chronic medical conditions [19]. The unique combi-
nation consisted of the simultaneous cross-national
development, the patient-derived bottom-up procedure, a
two modular design and the inclusion of seven chronic
conditions. This paper will illustrate the psychometric
procedures that have been employed in the development
of the condition-specific modules for the European DIS-
ABKIDS instrument. Results will be presented and limita-
tions will be discussed. A pilot study was performed to test
the basic domain structure and reduce the number of
items. A larger field study was conducted to carry out the
statistical analyses for the final version of the seven condi-
tion-specific DISABKIDS modules. The asthma-specific
module will be described in more detail to illustrate the
developmental process.
Methods
The DISABKIDS group has developed a European HRQoL
instrument for children and adolescents with a chronic
medical condition and their parents [19]. The project is a
collaboration of seven European countries (Austria,
France, Germany, Greece, the Netherlands, Sweden and
the United Kingdom) and included seven chronic medical
conditions: asthma, juvenile idiopathic arthritis (JIA),
atopic dermatitis, cerebral palsy (CP), cystic fibrosis (CF),
diabetes and epilepsy. The work was closely linked to the
KIDSCREEN project, which is concerned with the devel-
opment of a generic Quality of Life (QoL) questionnaire
for children of the general population through a similar
methodology [20,21]. The instruments devised by these
two projects form a three level modular structure (Figure
1).
The generic module is provided by the KIDSCREEN
project and is a QoL questionnaire, suitable for all chil-
dren, regardless of whether they enjoy complete health or
suffer from a chronic medical condition. This generic
module creates the possibility of comparing children with
a chronic condition to healthy children. The DISABKIDS
project has provided the other two modules. One is
referred to as the chronic generic module, which is suita-
ble for use with children and adolescents who suffer from
any chronic medical condition. It can compare HRQoL
across different conditions while taking into account spe-
cific areas affected by a chronic condition [22]. The third
level consists of a condition-specific module, one for
Modular design of the DISABKIDS* and KIDSCREEN† instru- ment Figure 1
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every chronic condition studied in the DISABKIDS
project. Each one concerns aspects related to a specific
chronic condition and can only compare between data
from patients with the same chronic condition. In practice
children and adolescents with a chronic medical condi-
tion can complete all three modules as each provides dif-
ferent information.
The DISABKIDS project has followed a stepwise method-
ology of questionnaire construction (Figure 2). Prior to
the development of the instrument, an extensive literature
review was conducted, and existing HRQoL question-
naires were reviewed in order to obtain an understanding
of items in use. Central to the DISABKIDS project was the
'bottom-up' (patient-derived) nature of questionnaire
construction, which was accomplished by involving chil-
dren and adolescents with a chronic medical condition
throughout the project. Focus groups and interviews were
carried out in order to identify important HRQoL aspects
from the perspective of children, adolescents and their
parents. The participants were asked a series of semi-struc-
tured questions designed to facilitate discussion about
their health and related quality of life issues. For example,
"What kinds of things keep you healthy?" or "How does
your condition affect you at school?". Participants were
also asked to make suggestions as to what questions could
be included in a QoL questionnaire suitable for others
who suffer from the same condition as them. In this way
the perspective of the child has been incorporated in order
to ensure that the content of the questionnaire is directly
relevant to the targeted age group [23].
HRQoL statements were selected from the collected qual-
itative data (focus group and interview transcripts) and
merged into a data bank. Collected statements from each
chronic condition group (asthma, epilepsy etc.) were then
divided among the three modules of the instrument (Fig-
ure 1). Statements that were considered relevant to all
children and adolescents, either healthy or suffering from
a chronic condition were entered in the generic module
and passed on to the KIDSCREEN project. General state-
ments concerning chronic medical conditions were
entered into the chronic generic module. Every disease
specific statement was placed in the appropriate condi-
tion-specific module. To minimise the number of items, a
redundancy scoring, item writing and card sorting proce-
dure was constructed [22]. The card sorting procedure was
performed by the DISABKIDS investigators and assisted in
the final item selection and provided a preliminary
domain structure for each module for use in the pilot
study. The selected items were translated to the appropri-
ate languages following general guidelines [24].
The aim of the pilot test was to select a reduced number of
items to be included in the field test and to determine a
preliminary scale structure within each condition-specific
module. At this stage it was considered important to inte-
grate both statistical and subjective data during the item
selection process. This included the percentage of 'not
applicable' and 'never' responses, a cognitive interview
and the clinical judgment of clinicians and investigators.
The cognitive interview provided detailed feedback on the
relevance, age appropriateness and comprehensibility of
the condition-specific items [25-27]. Children and adoles-
cents were asked to rate the difficulty of each item and to
rephrase each item in their own words. This feedback was
used in conjunction with statistical analyses in order to
make informed decisions about the item reduction [22].
The aim of the field test was to re-analyse the final domain
structure of each condition-specific module and to calcu-
late the internal consistency of each domain with data
from a larger cross-national sample. Items were also
examined for distribution of responses, frequency of non-
response, ceiling and floor effects.
Children and adolescents between 8 and 16 years of age
and their parents were asked to participate in the DISAB-
KIDS pilot and field study, completing the instrument
either at the hospital or at home. Data from the children
and adolescents were used for the statistical analyses.
Condition-specific modules were generally tested in at
least two or more countries; only asthma was tested in all
seven countries. Analysis of the condition-specific mod-
ules was carried out centrally (in the UK) to ensure that
Work packages within the DISABKIDS project Figure 2
Work packages within the DISABKIDS project.
• Literature review
• Focus groups 
• Item selection 
• Translations 
• Pilot study 
• Field study 
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the item selection was done in a consistent way across all
seven conditions. The analyses were performed separately
for each condition-specific module and were carried out
using SPSS Version 11.
Results
Pilot study
The pilot study instrument included the pilot version of
the chronic generic module (100 items) and the pilot ver-
sion of the condition-specific modules (between 26 and
44 items) (Table 1). The applied answer categories were
never, seldom, quite often, very often and always, which
were scored on a scale from 1 to 5 and an additional 'not
applicable' option. The pilot study was conducted
between May and August 2002.
The sample for the pilot study consisted of 360 participat-
ing families. An equal number of boys and girls (48% and
52%) were included, mean age 12.5 (SD 2.55). The
asthma group was the largest group of the sample (n =
132). Questionnaire data were only included when more
than 60% of the items were completed, resulting in a total
of 342 cases for the analyses. This left a few missing val-
ues, which were replaced with their series mean to evade
losing additional data.
Various sources of data were systematically considered in
the selection of items for domains. Some of the data were
qualitative in nature, for example the clinical opinion
gained from the relevant consultants participating in the
project, cognitive interview feedback from the children
and adolescents, and the investigator's judgement of the
quality of the item. These qualitative aspects were used in
conjunction with quantitative results from statistical anal-
yses of the pilot test data (missing values, floor and ceiling
effects). Some items were removed solely on the basis of
qualitative data when 3 or more qualitative factors were
identified as problematic (for example: not understood in
the cognitive interview, too many missing values and not
sufficiently related to HRQoL).
The structure of the condition-specific modules, as
derived from the card sort procedure, was used as a start-
ing point for the identification of domains within the
pilot test modules. Item-domain correlations and reliabil-
ity (Cronbach's alpha) were calculated for these scales.
The domain structures resulting from the card sorting
method were not generally robust in the statistical analy-
ses. Therefore, principal components analysis with var-
imax rotation was conducted in order to identify possible
new domains. The sample size was quite low for some
conditions, and therefore factor analyses were viewed
with caution.
An iterative procedure was followed in order to examine
possible domain structures. Item groupings, found in the
principal components analysis as being similar to those of
the original domain structures (from the card sort proce-
dure), were identified. On the basis of a similarity
between these two methods, 3–6 items were selected per
domain. A scale was then computed and the reliability cal-
culated. If the Cronbach's alpha (α) value was acceptable
(above 0.6 to 0.7) and could not be improved by the
removal of items, this was acknowledged as a domain
[28]. The process was carried out for all feasible domains
(typically two or three per condition). The resulting
domains were then correlated with all the remaining con-
dition-specific items. An item was added to a domain if it
correlated with a domain, it loaded only on one domain,
and it generally made sense to include the item in the
domain [29]. The reliability of the domain, including the
added items, was then re-calculated to ensure a good fit.
In some instances items were removed on the basis of low
corrected item-total correlations, which ideally should be
above 0.4 [28].
If the constructed domains displayed an unsatisfactory
(depending on group size and number of items) Cron-
bach's alpha value (i.e. α below a value of 0.7 to 0.6), the
factor analysis was repeated, restricting it to two or three
domains. This typically resulted in the grouping of similar
items that could be formed into possible new domains
(not necessarily those identified in the card sorting proce-
dure). If a domain contained too many items and had a
very high alpha value (α over 0.9), item-item correlations
were carried out to identify and consequently exclude
duplicate items.
Table 1: Number of items and participants (n = 360) in the pilot study for each condition-specific module
Condition-specific modules Number of items Number of participants Percentage of total sample (%)
Asthma 32 132 37
Juvenile idiopathic arthritis 44 54 15
Atopic dermatitis 36 29 8
Cerebral palsy 26 21 6
Cystic fibrosis 38 28 8
Diabetes mellitus 28 59 16
Epilepsy 27 37 10Health and Quality of Life Outcomes 2005, 3:70 http://www.hqlo.com/content/3/1/70
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When two or three domains had been identified with a
total of around 15 items, a final check was run that con-
sisted of the reliability of the domain, the item-domain
correlation, and conceptual analysis that included
whether or not the scale made sense. The internal consist-
ency of the domains in each condition-specific module
was between 0.75 and 0.89 (Table 2). Each domain was
given a label that represented the semantic content. Con-
sultants (with knowledge of a specific chronic condition)
within the DISABKIDS project were given the opportunity
of adding 1 or 2 items to a module on the basis of clinical
importance; these items were not added to the domains,
but were maintained as single items for separate analyses
after the field study.
Example: the asthma pilot study analysis
After the card sorting methodology the asthma module
originally consisted of 8 domains (Limitations, Symp-
toms, Worry, Allergy, Sleep, Medical, Interpersonal and
Lack of energy) with a total of 32 items. Analysis of the
module as described above (including information from
the cognitive interviews and clinical judgements) resulted
in a 2 domain structure (13 items). The domains were
labelled 'Impact' and 'Worry' due to their semantic con-
tent. The mean score on the 'Impact' domain was 3.63 (SD
0.82) and 4.15 (SD 0.89) on the 'Worry' domain. The DIS-
ABKIDS asthma consultants added two extra items, not
selected through statistical analysis but based on clinical
relevance.
Field study
The next step in the DISABKIDS project was the field study
(Figure 2), which took place between April and July 2003.
The sample for the field study consisted of 1152 partici-
pating families. The field study instrument included the
chronic generic module (56 items) [22] and the seven
condition-specific modules (between 14 and 19 items)
(Table 3). An equal number of boys and girls (52% vs.
48%) were included, mean age 12.2 (SD 2.8). The asthma
group was the largest in the sample (n = 405). Data from
1094 children and adolescents were used in the analysis,
selected on the basis of more than 60% of the items in the
module being completed.
At this stage the purpose of the analysis was to replicate
the domains found in the pilot test analysis. Principal
components analysis was carried out. Components that
were found to be similar to the pilot test domains (like the
asthma and CF module) were directly checked for reliabil-
ity. A domain was kept if the alpha value was above 0.7
and could not be improved by the removal or inclusion of
items.
All domains were correlated with each of the condition-
specific items. An item was added to a domain if it corre-
lated with the domain, it loaded clearly on one domain
and it generally made sense to include the item in the
domain. Items were removed if they loaded on more than
one domain (above 0.4 for each domain) or on the basis
of high item-item correlations (above 0.9) [29]. If neces-
sary, items were also removed from a domain on the basis
of low corrected item-total correlations and/or a substan-
tial increase in alpha value if removed. The internal con-
sistency of the domains was checked after each step. Each
procedure was repeated until the optimal solution was
found. In some cases domains were renamed or two
domains were merged (for example for the diabetes, JIA,
and atopic dermatitis modules). The internal consistency
of the domains for each condition-specific module was
between 0.71 and 0.90 (Table 4). It became clear that one
domain of each condition related to the actual impact of
the condition on a child or adolescent's life. These
domains were relabelled 'Impact'. Over half of the extra
items that were included on the basis of clinical relevance
after the pilot study analysis were integrated in the final
domains.
Example: the asthma field study analysis
The domain structure of the asthma pilot test analysis was
successfully replicated resulting in a 2 domain structure of
'Impact' and 'Worry', which consist of 6 and 5 items
respectively. Four items were removed on the basis of
duplication and low item-domain correlations, including
the two extra clinical items. The cumulative proportion of
the variance explained by the first two domains was 53%
and the internal consistency (α) was 0.83 and 0.84 (Table
4). The mean score on the 'Impact' domain was 3.61 (SD
Table 2: Domains, number of items (n) and the Cronbach's alpha (α) after the pilot analysis
Condition Domain 1 n α Domain 2 n α Domain 3 n α
Asthma Impact 8 .83 Worry 5 .86 . . .
Juvenile idiopathic arthritis Limitation 6 .82 Understanding 6 .75 Frustration 5 .77
Atopic dermatitis Impact 7 .84 Skin 5 .77 Shame 4 .77
Cerebral palsy Limitation 5 .84 Frustration 7 .81 . . .
Cystic fibrosis Impact 6 .77 Treatment 8 .87 . . .
Diabetes mellitus Impact 5 .84 Food 5 .76 Injections 5 .82
Epilepsy Fear 8 .89 Social 6 .77 . . .Health and Quality of Life Outcomes 2005, 3:70 http://www.hqlo.com/content/3/1/70
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0.91) and 4.17 (SD 0.84) on the 'Worry' domain. The
asthma-specific module was tested separately for all par-
ticipating DISABKIDS countries. The reliability in each
country was mostly above 0.8 (Table 5).
Discussion
This study describes part of the development process of
the seven DISABKIDS cross-national condition-specific
modules. The DISABKIDS instrument for children and
adolescents is the first to be developed cross-nationally in
collaboration with several European countries and to
include a chronic generic and condition-specific module.
The DISABKIDS instrument has several advantages. First
the construction of the chronic generic and condition-spe-
cific modules allows for a comprehensive assessment of
HRQoL. The chronic generic module can be used in con-
junction with any of the condition-specific modules.
Combining these modules gives the clinician and investi-
gator the unique opportunity to compare between coun-
tries and between different conditions.
The second advantage is the simultaneous cross-national
patient-derived development of the DISABKIDS instru-
ment. Children and adolescents from each DISABKIDS
country were included in the developmental process of
the instrument. HRQoL statements were collected from
the cross-national focus groups and interviews. Investiga-
tors from the DISABKIDS centres were involved in the
item selection process, assuring that all items where rele-
vant in each country. This was again tested in the cognitive
interview in the pilot study. This simultaneous setup in
different countries supported the developmental process
by taking into account cross-national consensus on
important HRQoL issues.
In addition, the construction of the DISABKIDS instru-
ment has been a reflective one, combining subjective and
statistical procedures. Item selection and reduction was
not carried out solely through the use of statistical meth-
ods, but also through the inclusion of qualitative factors,
such as the views of children and adolescents (gained
from cognitive interview) and clinical judgement. The
domain structure that resulted from the pilot test was to a
great extent successfully replicated after the field test. The
reliability of each domain was satisfactory in each condi-
tion-specific module.
However, some limitations should be given considera-
tion. The number of respondents in some condition
groups in both the pilot and the field test was relatively
small, CP (n = 21 and 43) and atopic dermatitis groups (n
= 29 and 65) in particular (Table 1 and 3). It was therefore
not possible to solely use statistical methods to develop
these modules. It is important to carry out further data
collection and to test the reliability and validity in larger
patient groups for these conditions. It will also be neces-
sary to carry out large cross-national studies in the future
in order to use modern psychometric methods based on
Item Response Theory (IRT), which will permit the testing
of differential item functioning across cultures and inform
the degree to which cross-national comparisons can be
Table 4: Domains, number of items (n) and Cronbach's alpha (α) after the field study analysis
Condition Domain 1 n α Domain 2 n α
Asthma Impact 6 .83 Worry 5 .84
Juvenile idiopathic arthritis Impact 9 .87 Understanding 3 .73
Atopic dermatitis Impact 8 .87 Stigma 4 .71
Cerebral palsy Impact 10 .82 Communication 2* .72
Cystic fibrosis Impact 4 .80 Treatment 6 .85
Diabetes mellitus Impact 6 .83 Treatment 4 .84
Epilepsy Impact 5 .90 Social 5 .84
*With only two items this is the inter-item correlation.
Table 3: Number of items and participants (n = 1152) in the field study for each condition-specific module
Condition Number of items Number of participants Percentage of total sample (%)
Asthma 15 405 35
Juvenile idiopathic arthritis 19 150 13
Atopic dermatitis 19 65 5
Cerebral palsy 16 43 4
Cystic fibrosis 14 91 8
Diabetes mellitus 15 207 18
Epilepsy 16 191 17Health and Quality of Life Outcomes 2005, 3:70 http://www.hqlo.com/content/3/1/70
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validly made. The use of such IRT-based tests was not pos-
sible at this stage of the development of the measure
because IRT methods require very large sample sizes.
A second limitation is that the condition-specific modules
were not tested in every country. Only asthma was tested
in all the participating DISABKIDS countries. The Cron-
bach's alphas were adequate for each asthma domain in
each country. The lower alphas in Greece might not only
be due to lower numbers of tested participants but also to
the fact that the researched population included mostly
exercise-induced asthma, which might result in a different
impact on their HRQoL. As the number of participants in
the other chronic conditions was generally low the relia-
bility per country will still need to be explored in more
detail.
Future studies will be necessary to provide more details on
the reliability and validity of the DISABKIDS modules,
especially in larger groups and in different countries. Evi-
dence also needs to be supplied on the value of the instru-
ment in clinical practice. Further possibilities include
testing the chronic generic module for applicability in
other chronic medical conditions (e.g. haemophilia, heart
disease or obesity).
The developmental steps within the DISABKIDS project
have included a combination of qualitative and quantita-
tive methods. The two methods were used in succession in
order to complement each other, as has been the case
throughout the DISABKIDS project. The qualitative data
(cognitive interview and clinical judgement) collected in
the pilot study was first used to disregard irrelevant items.
This was followed by the psychometric calculations. In
some cases the project members found removed items to
be clinically relevant. These were therefore added as the
two extra items in the field study.
Although the process of item reduction for each of the
condition-specific modules was similar and included well
know procedures [28,29], it remains difficult to describe
the developmental process. As the value of each test
depended on the size of the group and the number of
items in the domain, and common sense judgements
were also included, the taken steps may not always seem
transparent. The number of countries included in the
study meant that there were more national factors and
individual opinions to include. Several processes within
the DISABKIDS project (team meetings, group discus-
sions) have influenced decisions. An example was the
post-hoc decision to add extra items based on clinical rel-
evance.
Conclusion
The condition-specific modules for the DISABKIDS
instrument were developed through a step-by-step process
including cognitive interview, clinical expertise, factor
analysis, correlations and reliabilities. The seven condi-
tion-specific modules consist of an 'Impact' domain and
an additional domain with a total of 10 to 12 items.
The DISABKIDS project has constructed a unique instru-
ment, which was developed cross-nationally, included the
patient's perspective and has a chronic generic module,
which can be combined with one of the seven condition-
specific modules. The expectation is that the instrument
will be used in a wide variety of (international) studies of
children and adolescents with common disorders of
childhood.
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